Find the resources you need.
Locate A Chapter
Liver Disease and
Related Topics
Liver Disease Glossary
Know the terms, understand your care
ClinicalTrials.gov
A service of the U.S. National Institute of Health
Call Us! 1-800-GO-LIVER

Throughout the year our chapters organize fundraising events including dinners, galas, walks and runs.
Home > About ALF > Media Center
The American Liver Foundation (ALF), a national nonprofit organization that provides education, advocacy and research on behalf of the 30 million Americans affected by liver disease, today commented on the new rules on drug labeling which the FDA has just proposed.
New York, December 21, 2006 – The American Liver Foundation (ALF), a national nonprofit organization that provides education, advocacy and research on behalf of the 30 million Americans affected by liver disease, today commented on the new rules on drug labeling which the FDA has just proposed.
The proposed rules include the highlighting of the word “acetaminophen” on all products containing the product and adding specific language to product labeling. The FDA also recommended similar changes to labeling on all over the counter products containing a NSAID (nonsteroidal anti-inflammatory drug) ingredient, such as ibuprofen. Excess acetaminophen can damage the liver and NSAIDs can cause kidney damage and internal bleeding if not taken properly.
“It is crucial for people to understand what drugs they are putting into their system,” said Dr. James Boyer, chairman of the board of directors of the American Liver Foundation. “Acetaminophen is a wonderful drug, something I regularly prescribe for my patients with liver disease. The crucial issue is to take the correct amount of the drug and no more. We feel the new information on the labels will help people understand the proper dosage of all of these products.”
Key Facts About Liver Disease
About the American Liver Foundation
The American Liver Foundation is the nation’s leading nonprofit organization promoting liver health and disease prevention. ALF provides research, education and advocacy for those affected by liver-related diseases including hepatitis. Please visit the American Liver Foundation’s Web site at www.liverfoundation.org
Page updated: March 14th, 2007
© Copyright 2008 American Liver Foundation. All Rights Reserved.